TMCI:NASDAQ
Treace Medical Concepts, Inc
4,56 USD
arrow_upward
+1,67%(+0,075) 1D
29-сен., 12:51:12 GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMCI...
Open
4,48 USD
High
4,56 USD
Low
4,41 USD
Mkt. cap
296,23 млн
Avg. vol.
253,23 миң
Volume
38,50 миң
52-wk high
7,08 USD
52-wk low
1,17 USD
EPS
-0,93 USD
Beta
1,41
Shares outstanding
65,04 млн
No. of employees
450
Open
4,48 USD
High
4,56 USD
Low
4,41 USD
Mkt. cap
296,23 млн
Avg. vol.
253,23 миң
Volume
38,50 миң
52-wk high
7,08 USD
52-wk low
1,17 USD
EPS
-0,93 USD
Beta
1,41
Shares outstanding
65,04 млн
No. of employees
450
Profile
Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions.
In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021. Wikipedia
About Treace Medical Concepts, Inc